{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:26:39Z","timestamp":1787037999932,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Joint Funds for the innovation of science and Technology, Fujian province","award":["2023Y9134"],"award-info":[{"award-number":["2023Y9134"]}]},{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2023QH1029"],"award-info":[{"award-number":["2023QH1029"]}]},{"name":"Fujian Provincial Science and Technology Plan Project-University Industry Collaboration Project","award":["2023Y4005"],"award-info":[{"award-number":["2023Y4005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00228-026-04138-z","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:26:46Z","timestamp":1783726006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacogenomic screening strategy and indicative screening efficiency for antithyroid drug-induced agranulocytosis in the Southern Han Chinese"],"prefix":"10.1007","volume":"82","author":[{"given":"Li","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujie","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiji","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanlian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiyu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"4138_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra042972","volume":"352","author":"DS Cooper","year":"2005","unstructured":"Cooper DS (2005) Antithyroid drugs. N Engl J Med 352:905\u2013917. https:\/\/doi.org\/10.1056\/NEJMra042972","journal-title":"N Engl J Med"},{"key":"4138_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1507\/endocrj.EJ12-0332","volume":"60","author":"J Yang","year":"2013","unstructured":"Yang J, Zhong J, Xiao XH et al (2013) The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis. Endocr J 60:185\u2013189. https:\/\/doi.org\/10.1507\/endocrj.EJ12-0332","journal-title":"Endocr J"},{"key":"4138_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1600-0609.1988.tb00803.x","volume":"40","author":"D Douer","year":"1988","unstructured":"Douer D, Eisenstein Z (1988) Methimazole-induced agranulocytosis: growth inhibition of myeloid progenitor cells by the patient\u2019s serum. Eur J Haematol 40:91\u201394. https:\/\/doi.org\/10.1111\/j.1600-0609.1988.tb00803.x","journal-title":"Eur J Haematol"},{"key":"4138_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1517\/17425255.2015.985649","volume":"11","author":"A Johnston","year":"2015","unstructured":"Johnston A, Uetrecht J (2015) Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert Opin Drug Metab Toxicol 11:243\u2013257. https:\/\/doi.org\/10.1517\/17425255.2015.985649","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4138_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3186328","volume":"2017","author":"WL Fan","year":"2017","unstructured":"Fan WL, Shiao MS, Hui RCY et al (2017) HLA association with drug-induced adverse reactions. J Immunol Res 2017:1\u201310. https:\/\/doi.org\/10.1155\/2017\/3186328","journal-title":"J Immunol Res"},{"key":"4138_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00251-017-1007-5","volume":"69","author":"PT Illing","year":"2017","unstructured":"Illing PT, Purcell AW, McCluskey J (2017) The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions. Immunogenetics 69:617\u2013630. https:\/\/doi.org\/10.1007\/s00251-017-1007-5","journal-title":"Immunogenetics"},{"key":"4138_CR7","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1038\/ncomms8633","volume":"6","author":"PL Chen","year":"2015","unstructured":"Chen PL, Shih SR, Wang PW et al (2015) Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. Nat Commun 6:7633. https:\/\/doi.org\/10.1038\/ncomms8633","journal-title":"Nat Commun"},{"key":"4138_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/cpt.309","volume":"99","author":"CL Cheung","year":"2016","unstructured":"Cheung CL, Sing CW, Tang CS et al (2016) HLA-B*38:02:01 predicts carbimazole\/methimazole-induced agranulocytosis. Clin Pharmacol Ther 99:555\u2013561. https:\/\/doi.org\/10.1002\/cpt.309","journal-title":"Clin Pharmacol Ther"},{"key":"4138_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S2213-8587(16)00113-3","volume":"4","author":"P Hallberg","year":"2016","unstructured":"Hallberg P, Eriksson N, Iba\u00f1ez L et al (2016) Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population. Lancet Diabetes Endocrinol 4:507\u2013516. https:\/\/doi.org\/10.1016\/S2213-8587(16)00113-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4138_CR10","doi-asserted-by":"publisher","first-page":"11950","DOI":"10.1038\/s41598-017-12350-2","volume":"7","author":"Y He","year":"2017","unstructured":"He Y, Zheng J, Zhang Q et al (2017) Association of HLA-B and HLA-DRB1 polymorphisms with antithyroid drug-induced agranulocytosis in a Han population from northern China. Sci Rep 7:11950. https:\/\/doi.org\/10.1038\/s41598-017-12350-2","journal-title":"Sci Rep"},{"key":"4138_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1089\/thy.2015.0439","volume":"26","author":"J Yang","year":"2016","unstructured":"Yang J, Zhu YJ, Zhong JJ et al (2016) Characteristics of antithyroid drug-induced agranulocytosis in patients with hyperthyroidism: a retrospective analysis of 114 cases in a single institution in China involving 9690 patients referred for radioiodine treatment over 15 years. Thyroid 26:627\u2013633. https:\/\/doi.org\/10.1089\/thy.2015.0439","journal-title":"Thyroid"},{"key":"4138_CR12","unstructured":"(1991) Drug-induced cytopenia standardization of definitions and criteria of causality assessment of adverse drug reactions. Int J Clin Pharmacol Ther Toxicol 29:75\u201381"},{"key":"4138_CR13","volume-title":"The use of the WHO-UMC system for standardised case causality assessment","author":"Uppsala Monitoring Centre","year":"2015","unstructured":"Uppsala Monitoring Centre (2015) The use of the WHO-UMC system for standardised case causality assessment. Uppsala Monitoring Centre, Uppsala. http:\/\/who-umc.org\/Graphics\/24734.pdf"},{"key":"4138_CR14","doi-asserted-by":"publisher","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","volume":"39","author":"FF Gonzalez-Galarza","year":"2011","unstructured":"Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR (2011) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 39:D913\u2013D919. https:\/\/doi.org\/10.1093\/nar\/gkq1128","journal-title":"Nucleic Acids Res"},{"key":"4138_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1399-0039.2007.00932.x","volume":"70","author":"E Trachtenberg","year":"2007","unstructured":"Trachtenberg E, Vinson M, Hayes E et al (2007) HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. Tissue Antigens 70:455\u2013463. https:\/\/doi.org\/10.1111\/j.1399-0039.2007.00932.x","journal-title":"Tissue Antigens"},{"key":"4138_CR16","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1182\/blood.V89.11.4167","volume":"89","author":"D Turbay","year":"1997","unstructured":"Turbay D, Lieberman J, Alper CA et al (1997) Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups. Blood 89:4167\u20134174. https:\/\/doi.org\/10.1182\/blood.V89.11.4167","journal-title":"Blood"},{"key":"4138_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1046\/j.1399-0039.2003.00133.x","volume":"62","author":"O Ostrousky","year":"2003","unstructured":"Ostrousky O, Meged S, Loewenthal R et al (2003) NQO2 gene is associated with clozapine-induced agranulocytosis. Tissue Antigens 62:483\u2013491. https:\/\/doi.org\/10.1046\/j.1399-0039.2003.00133.x","journal-title":"Tissue Antigens"},{"key":"4138_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41397-020-00187-4","volume":"21","author":"S Nakakura","year":"2021","unstructured":"Nakakura S, Hosomichi K, Uchino S et al (2021) HLA-B*39:01:01 is a novel risk factor for antithyroid drug-induced agranulocytosis in Japanese population. Pharmacogenomics J 21:94\u2013101. https:\/\/doi.org\/10.1038\/s41397-020-00187-4","journal-title":"Pharmacogenomics J"},{"key":"4138_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7965346","volume":"2018","author":"MP Thao","year":"2018","unstructured":"Thao MP, Tuan PVA, Linh LGH et al (2018) Association of HLA-B\u221738:02 with antithyroid drug-induced agranulocytosis in Kinh Vietnamese patients. Int J Endocrinol 2018:1\u20135. https:\/\/doi.org\/10.1155\/2018\/7965346","journal-title":"Int J Endocrinol"},{"key":"4138_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1399-0039.2006.00529.x","volume":"67","author":"G Yang","year":"2006","unstructured":"Yang G, Deng YJ, Hu SN et al (2006) HLA-A, \u2013B, and -DRB1 polymorphism defined by sequence-based typing of the Han population in Northern China. Tissue Antigens 67:146\u2013152. https:\/\/doi.org\/10.1111\/j.1399-0039.2006.00529.x","journal-title":"Tissue Antigens"},{"key":"4138_CR21","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1093\/molbev\/msaa276","volume":"38","author":"YH Lo","year":"2021","unstructured":"Lo YH, Cheng HC, Hsiung CN et al (2021) Detecting genetic ancestry and adaptation in the Taiwanese Han People. Mol Biol Evol 38:4149\u20134165. https:\/\/doi.org\/10.1093\/molbev\/msaa276","journal-title":"Mol Biol Evol"},{"key":"4138_CR22","doi-asserted-by":"publisher","first-page":"1525307","DOI":"10.3389\/fphar.2025.1525307","volume":"16","author":"S Wu","year":"2025","unstructured":"Wu S, Huang L, Chen J, Xie X, Huang S, Huang X (2025) Non-chemotherapy drugs inducing agranulocytosis: a disproportionality analysis based on the FAERS database. Front Pharmacol 16:1525307. https:\/\/doi.org\/10.3389\/fphar.2025.1525307","journal-title":"Front Pharmacol"},{"key":"4138_CR23","doi-asserted-by":"publisher","first-page":"1431941","DOI":"10.3389\/fphar.2024.1431941","volume":"15","author":"X Huang","year":"2024","unstructured":"Huang X, Xie X, Huang S, Wu S, Huang L (2024) Predicting non-chemotherapy drug-induced agranulocytosis toxicity through ensemble machine learning approaches. Front Pharmacol 15:1431941. https:\/\/doi.org\/10.3389\/fphar.2024.1431941","journal-title":"Front Pharmacol"},{"key":"4138_CR24","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","volume":"364","author":"P Chen","year":"2011","unstructured":"Chen P, Lin JJ, Lu CS et al (2011) Carbamazepine-induced toxic effects and HLA-b*1502 screening in Taiwan. N Engl J Med 364:1126\u20131133. https:\/\/doi.org\/10.1056\/NEJMoa1009717","journal-title":"N Engl J Med"},{"key":"4138_CR25","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1212\/WNL.0b013e31826aac73","volume":"79","author":"D Dong","year":"2012","unstructured":"Dong D, Sung C, Finkelstein EA (2012) Cost-effectiveness of HLA-b*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore. Neurology 79:1259\u20131267. https:\/\/doi.org\/10.1212\/WNL.0b013e31826aac73","journal-title":"Neurology"},{"key":"4138_CR26","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1136\/bmj.h4848","volume":"351","author":"TM Ko","year":"2015","unstructured":"Ko TM, Tsai CY, Chen SY et al (2015) Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. BMJ 351:4848","journal-title":"BMJ"},{"key":"4138_CR27","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1093\/rheumatology\/kex253","volume":"56","author":"CO Plumpton","year":"2017","unstructured":"Plumpton CO, Alfirevic A, Pirmohamed M, Hughes DA (2017) Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout. Rheumatol (Oxf Engl) 56:1729\u20131739. https:\/\/doi.org\/10.1093\/rheumatology\/kex253","journal-title":"Rheumatol (Oxf Engl)"},{"key":"4138_CR28","first-page":"969","volume":"41","author":"Chinese Society of Hematology, Chinese Medical Association","year":"2020","unstructured":"Chinese Society of Hematology, Chinese Medical Association (2020) Chinese guidelines for the clinical application of antibacterial drugs for febrile neutropenia (2020) Hematologist branch of Chinese Medical Doctor Association. Chin J Hematol 41:969\u2013978","journal-title":"Chin J Hematol"},{"key":"4138_CR29","doi-asserted-by":"publisher","first-page":"E49","DOI":"10.1210\/jc.2011-2221","volume":"97","author":"N Watanabe","year":"2012","unstructured":"Watanabe N, Narimatsu H, Noh JY et al (2012) Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves\u2019 disease. J Clin Endocrinol Metab 97:E49\u2013E53. https:\/\/doi.org\/10.1210\/jc.2011-2221","journal-title":"J Clin Endocrinol Metab"},{"key":"4138_CR30","doi-asserted-by":"publisher","first-page":"727717","DOI":"10.3389\/fphar.2021.727717","volume":"12","author":"B Rattay","year":"2021","unstructured":"Rattay B, Benndorf RA (2021) Drug-induced idiosyncratic agranulocytosis\u2014infrequent but dangerous. Front Pharmacol 12:727717. https:\/\/doi.org\/10.3389\/fphar.2021.727717","journal-title":"Front Pharmacol"},{"key":"4138_CR31","doi-asserted-by":"publisher","first-page":"178253","DOI":"10.1172\/JCI178253","volume":"134","author":"PN Shah","year":"2024","unstructured":"Shah PN, Romar GA, Manukyan A et al (2024) Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets. J Clin Invest 134:178253. https:\/\/doi.org\/10.1172\/JCI178253","journal-title":"J Clin Invest"},{"key":"4138_CR32","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","volume":"129","author":"CY Wei","year":"2012","unstructured":"Wei CY, Chung WH, Huang HW, Chen YT, Hung SI (2012) Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. J Allergy Clin Immunol 129:1562\u20131569e5. https:\/\/doi.org\/10.1016\/j.jaci.2011.12.990","journal-title":"J Allergy Clin Immunol"},{"key":"4138_CR33","doi-asserted-by":"publisher","first-page":"658593","DOI":"10.3389\/fimmu.2021.658593","volume":"12","author":"J Pratoomwun","year":"2021","unstructured":"Pratoomwun J, Thomson P, Jaruthamsophon K et al (2021) Characterization of T-cell Responses to SMX and SMX-NO in co-trimoxazole hypersensitivity patients expressing HLA-B*13:01. Front Immunol 12:658593. https:\/\/doi.org\/10.3389\/fimmu.2021.658593","journal-title":"Front Immunol"},{"key":"4138_CR34","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1021\/tx400060p","volume":"26","author":"CC Bell","year":"2013","unstructured":"Bell CC, Faulkner L, Martinsson K et al (2013) T-cells from HLA-B*57:01\u2009+\u2009Human Subjects Are Activated with Abacavir through Two Independent Pathways and Induce Cell Death by Multiple Mechanisms. Chem Res Toxicol 26:759\u2013766. https:\/\/doi.org\/10.1021\/tx400060p","journal-title":"Chem Res Toxicol"},{"key":"4138_CR35","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1111\/all.15814","volume":"78","author":"NA Mifsud","year":"2023","unstructured":"Mifsud NA, Illing PT, Ho R et al (2023) The allopurinol metabolite, oxypurinol, drives oligoclonal expansions of drug-reactive T cells in resolved hypersensitivity cases and drug-na\u00efve healthy donors. Allergy 78:2980\u20132993. https:\/\/doi.org\/10.1111\/all.15814","journal-title":"Allergy"},{"key":"4138_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1365-2257.2002.00437.x","volume":"24","author":"E Andr\u00e8s","year":"2002","unstructured":"Andr\u00e8s E, Kurtz JE, Maloisel F (2002) Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985\u20132000) and review of the literature. Int J Lab Hematol 24:99\u2013106. https:\/\/doi.org\/10.1046\/j.1365-2257.2002.00437.x","journal-title":"Int J Lab Hematol"},{"key":"4138_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1054\/mehy.1998.0734","volume":"53","author":"I Guest","year":"1999","unstructured":"Guest I, Uetrecht J (1999) Drugs that induce neutropenia\/agranulocytosis may target specific components of the stromal cell extracellular matrix. Med Hypotheses 53:145\u2013151. https:\/\/doi.org\/10.1054\/mehy.1998.0734","journal-title":"Med Hypotheses"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04138-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04138-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04138-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:55:36Z","timestamp":1787036136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04138-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4138"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04138-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Medical Ethics Committee of Fujian Medical University Union Hospital (permit 2019YF036-01) and was registered with the Chinese Clinical Trial Registry (ChiCTR1900028690). The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in the study. Consent for the use of human blood samples for research and publication was obtained in accordance with institutional guidelines. All patient data and clinical samples were strictly anonymized prior to analysis to protect patient identity.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"203"}}